Added to YB: 2026-10-15
Pitch date: 2026-10-13
IDXX [bullish]
IDEXX Laboratories, Inc.
+1.64%
current return
Author Info
Business Model Mastery is a daily, easily digestible guide to mastering how businesses work. Build a mental database of companies, compare opportunities, and quickly assess business models with confidence—gaining an edge over other market participants. Sign up for the newsletter.
Company Info
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally.
Market Cap
$41.3B
Pitch Price
$520.20
Price Target
N/A
Dividend
N/A
EV/EBITDA
25.37
P/E
36.84
EV/Sales
9.26
Sector
Health Care Equipment and Supplies
Category
growth
IDEXX Laboratories: The Analyzer Opens the Door. The Tests Keep the Veterinary Clinic Paying.
IDXX (monitor): IDEXX’s installed analyzers underpin recurring diagnostics revenue, while integrated workflows and high-90% retention support an attractive model with 64% gross and 35% operating margins in Q2 2026. Recurring diagnostic revenue grew 8% organically in 2025 despite U.S. same-clinic visits declining roughly 2%, then accelerated to 10% in Q2. At $300-$350, estimated 8%-10% annual returns over ten years depend on preserving its competitive advantage and normalized earning capacity; the testing-per-patient mix needs deeper work.
Read full article (4 min)